345 related articles for article (PubMed ID: 30423463)
1. Omega-3 polyunsaturated fatty acids and psychological intervention for workers with mild to moderate depression: A double-blind randomized controlled trial.
Tayama J; Ogawa S; Nakaya N; Sone T; Hamaguchi T; Takeoka A; Hamazaki K; Okamura H; Yajima J; Kobayashi M; Hayashida M; Shirabe S
J Affect Disord; 2019 Feb; 245():364-370. PubMed ID: 30423463
[TBL] [Abstract][Full Text] [Related]
2. Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial.
Carney RM; Freedland KE; Rubin EH; Rich MW; Steinmeyer BC; Harris WS
JAMA; 2009 Oct; 302(15):1651-7. PubMed ID: 19843899
[TBL] [Abstract][Full Text] [Related]
3. Omega-3 polyunsaturated fatty acids in cardiovascular diseases comorbid major depressive disorder - Results from a randomized controlled trial.
Chang JP; Chang SS; Yang HT; Chen HT; Chien YC; Yang B; Su H; Su KP
Brain Behav Immun; 2020 Mar; 85():14-20. PubMed ID: 30902738
[TBL] [Abstract][Full Text] [Related]
4. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials.
Martins JG
J Am Coll Nutr; 2009 Oct; 28(5):525-42. PubMed ID: 20439549
[TBL] [Abstract][Full Text] [Related]
5. The synchronized trial on expectant mothers with depressive symptoms by omega-3 PUFAs (SYNCHRO): Study protocol for a randomized controlled trial.
Nishi D; Su KP; Usuda K; Chiang YJ; Guu TW; Hamazaki K; Nakaya N; Sone T; Sano Y; Tachibana Y; Ito H; Isaka K; Hashimoto K; Hamazaki T; Matsuoka YJ
BMC Psychiatry; 2016 Sep; 16(1):321. PubMed ID: 27630014
[TBL] [Abstract][Full Text] [Related]
6. Long-Chain Omega-3 Fatty Acid Supplements in Depressed Heart Failure Patients: Results of the OCEAN Trial.
Jiang W; Whellan DJ; Adams KF; Babyak MA; Boyle SH; Wilson JL; Patel CB; Rogers JG; Harris WS; O'Connor CM
JACC Heart Fail; 2018 Oct; 6(10):833-843. PubMed ID: 30098961
[TBL] [Abstract][Full Text] [Related]
7. Omega-3 polyunsaturated fatty acids (n-3 PUFAs), somatic and fatigue symptoms in cardiovascular diseases comorbid major depressive disorder (MDD): A randomized controlled trial.
Chang JP; Chang SS; Chen HT; Chien YC; Yang HT; Huang SY; Tseng PT; Chang CH; Galecki P; Su KP
Brain Behav Immun; 2023 Aug; 112():125-131. PubMed ID: 37301235
[TBL] [Abstract][Full Text] [Related]
8. Effects of omega-3 fatty acids on depression and quality of life in maintenance hemodialysis patients.
Dashti-Khavidaki S; Gharekhani A; Khatami MR; Miri ES; Khalili H; Razeghi E; Hashemi-Nazari SS; Mansournia MA
Am J Ther; 2014; 21(4):275-87. PubMed ID: 24987942
[TBL] [Abstract][Full Text] [Related]
9. Tachikawa project for prevention of posttraumatic stress disorder with polyunsaturated fatty acid (TPOP): study protocol for a randomized controlled trial.
Matsuoka Y; Nishi D; Yonemoto N; Hamazaki K; Matsumura K; Noguchi H; Hashimoto K; Hamazaki T
BMC Psychiatry; 2013 Jan; 13():8. PubMed ID: 23289548
[TBL] [Abstract][Full Text] [Related]
10. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial.
Andrieu S; Guyonnet S; Coley N; Cantet C; Bonnefoy M; Bordes S; Bories L; Cufi MN; Dantoine T; Dartigues JF; Desclaux F; Gabelle A; Gasnier Y; Pesce A; Sudres K; Touchon J; Robert P; Rouaud O; Legrand P; Payoux P; Caubere JP; Weiner M; Carrié I; Ousset PJ; Vellas B;
Lancet Neurol; 2017 May; 16(5):377-389. PubMed ID: 28359749
[TBL] [Abstract][Full Text] [Related]
11. Omega-3 supplementation from pregnancy to postpartum to prevent depressive symptoms: a randomized placebo-controlled trial.
Vaz JDS; Farias DR; Adegboye ARA; Nardi AE; Kac G
BMC Pregnancy Childbirth; 2017 Jun; 17(1):180. PubMed ID: 28599630
[TBL] [Abstract][Full Text] [Related]
12. Effects of omega-3 polyunsaturated fatty acids on psychophysiological symptoms of post-traumatic stress disorder in accident survivors: A randomized, double-blind, placebo-controlled trial.
Matsumura K; Noguchi H; Nishi D; Hamazaki K; Hamazaki T; Matsuoka YJ
J Affect Disord; 2017 Dec; 224():27-31. PubMed ID: 27287561
[TBL] [Abstract][Full Text] [Related]
13. Omega-3 polyunsaturated fatty acids supplementation improves memory in first-diagnosed, drug-naïve patients with depression: Secondary analysis of data from a randomized controlled trial.
Xue Y; Wang L; Liu T; Zhao T; Xie K; Guo J; Chen J; Tang H; Tang M
J Affect Disord; 2024 Apr; 350():403-410. PubMed ID: 38244783
[TBL] [Abstract][Full Text] [Related]
14. Differences between Japan and Taiwan in the treatment of pregnant women with depressive symptoms by omega-3 fatty acids: An open-label pilot study.
Nishi D; Su KP; Usuda K; Chang JP; Chiang YJ; Guu TW; Hamazaki K; Nakaya N; Sone T; Hashimoto K; Hamazaki T; Matsuoka YJ
Nutr Neurosci; 2019 Jan; 22(1):63-71. PubMed ID: 28752805
[TBL] [Abstract][Full Text] [Related]
15. Effect of omega-3 fatty acids supplementation on depressive symptoms and on health-related quality of life in the treatment of elderly women with depression: a double-blind, placebo-controlled, randomized clinical trial.
Rondanelli M; Giacosa A; Opizzi A; Pelucchi C; La Vecchia C; Montorfano G; Negroni M; Berra B; Politi P; Rizzo AM
J Am Coll Nutr; 2010 Feb; 29(1):55-64. PubMed ID: 20595646
[TBL] [Abstract][Full Text] [Related]
16. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial.
Nogueira MA; Oliveira CP; Ferreira Alves VA; Stefano JT; Rodrigues LS; Torrinhas RS; Cogliati B; Barbeiro H; Carrilho FJ; Waitzberg DL
Clin Nutr; 2016 Jun; 35(3):578-86. PubMed ID: 26047766
[TBL] [Abstract][Full Text] [Related]
17. Eicosapentaenoic acid versus docosahexaenoic acid in mild-to-moderate depression: a randomized, double-blind, placebo-controlled trial.
Mozaffari-Khosravi H; Yassini-Ardakani M; Karamati M; Shariati-Bafghi SE
Eur Neuropsychopharmacol; 2013 Jul; 23(7):636-44. PubMed ID: 22910528
[TBL] [Abstract][Full Text] [Related]
18. Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.
da Silva TM; Munhoz RP; Alvarez C; Naliwaiko K; Kiss A; Andreatini R; Ferraz AC
J Affect Disord; 2008 Dec; 111(2-3):351-9. PubMed ID: 18485485
[TBL] [Abstract][Full Text] [Related]
19. Adjunctive treatment of chronic periodontitis with daily dietary supplementation with omega-3 Fatty acids and low-dose aspirin.
El-Sharkawy H; Aboelsaad N; Eliwa M; Darweesh M; Alshahat M; Kantarci A; Hasturk H; Van Dyke TE
J Periodontol; 2010 Nov; 81(11):1635-43. PubMed ID: 20572767
[TBL] [Abstract][Full Text] [Related]
20. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study.
Chiu CC; Su KP; Cheng TC; Liu HC; Chang CJ; Dewey ME; Stewart R; Huang SY
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1538-44. PubMed ID: 18573585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
